David M. Simpson, MD: A Leader in Botulinum Toxin Research
David M. Simpson, MD, Professor of Neurology and Director of the Clinical Neurophysiology Laboratories at Mount Sinai, is a leader in the research of targeted treatment for spasticity using botulinum toxin.
Dr. Simpson headed a research team that performed and published the first placebo-controlled study demonstrating the safety and effectiveness of botulinum toxin (Botox®) in the treatment of post-stroke spasticity. Further studies by Dr. Simpson’s group demonstrated the superiority of botulinum toxin over oral anti-spasticity medications.
Dr. Simpson has launched several studies to perfect the technique of botulinum toxin injection. He has lectured and published extensively in this area and trained physicians throughout the world in this innovative therapy.
Dr. Simpson chaired a panel chartered by the American Academy of Neurology to develop evidence-based guidelines on the use of botulinum toxin for a wide range of neurological diseases, including adult and childhood spasticity, movement disorders such as cervical dystonia and blepharospasm, pain, including chronic migraine, and autonomic disorders, such as hyperhidrosis (excessive sweating).
Dr. Simpson is available to see patients. To schedule an appointment, please call 212-241-8748.